Donald Danforth Plant Science Center competitors

Jeff Albers is the chief executive officer of [Blueprint Medicines](https://www.crunchbase.com/organization/blueprint-medicines), a company engaged in the discovery and development of highly selective kinase inhibitors for genomically defined cancer subsets. He was previously the president of Algeta. Prior to Algeta, he served at Genzyme, where he spent seven years in senior commercial and corporate development positions. Before joining Genzyme, he spent five years as an Attorney at the law firm Mintz Levin Cohn Ferris Glovsky & Popeo. He also has prior experience as a sales representative for Pfizer. Albers holds a bachelor’s degree in marketing from Indiana University and an MBA from Georgetown University.

Sejal Palande is a Joint Chief Executive Officer at American Chemical Society (ACS) and is based in Thane, Maharashtra, India. She has worked as Management Intern at robotics, Embedded System and Robotics at Team Robocon KJSIEIT, and Trainee at Vital Electronics And Manufacturing Corporate. Sejal studied at Dr Datar Science Dr Behere Arts and Shri Pilukaka Joshi Commerce College S K Patil Nagar Chiplun Tal Chiplun Dist Ratnagiri 415 605, Gharda Foundations Gharda Institute Of Technology At & Post Lavel Tal Khed Dist Ratnagiri between 2017 and 2018, and K. J. Somaiya Institute of Engineering and Information Technology between 2018 and 2021.

Stefano Bertuzzi is a Chief Executive Officer at American Society for Microbiology and is based in Washington, District of Columbia. He has worked as Director, Office of Science Policy, Planning and Communications at National Institute of Mental Health (NIMH); Research Associate at Salk Institute; and Senior Scientific Executive at National Institutes of Health. Stefano studied at Johns Hopkins University between 2009 and 2011 and Università Cattolica between 1991 and 1995.